Treatment of enteric fever ??

Reading File
Finding Sources
Searching PubMed

"typhoid fever" AND treatment

Searching the Web

enteric fever typhoid treatment guidelines antibiotics 2024

Reading File
Reading File
Reading File

Treatment of Enteric Fever (Typhoid/Paratyphoid Fever)

Enteric fever is caused by Salmonella Typhi or Paratyphi (A, B, C). Management rests on three pillars: antibiotics, supportive care, and management of complications, guided by local antimicrobial resistance patterns since resistance varies widely by region.

1. Antibiotic Therapy

Empiric choice depends on likely resistance pattern (travel history/region):
ScenarioFirst-line regimen
Fully susceptible strainFluoroquinolone: ciprofloxacin 500 mg PO twice daily (or 400 mg IV twice daily) x 7-14 days
Multidrug-resistant (MDR) region or unknown susceptibility (e.g. South Asia)Azithromycin 1 g PO on day 1, then 500 mg PO once daily x 6 days (total 7 days); or ceftriaxone 2 g IV/IM every 12-24 h (children 75 mg/kg/day) x 7-14 days
Extensively drug-resistant (XDR) strains (notably Pakistan, also reported in Iraq)Azithromycin (oral, uncomplicated disease) or a carbapenem such as meropenem 1 g IV every 8 h for severe/complicated disease x 7-14 days
Confirmed susceptible isolateAmpicillin, chloramphenicol, or trimethoprim-sulfamethoxazole are alternatives if susceptibility is documented
  • Duration: generally at least 10 days, or continued until 5 days after fever resolves.
  • Defervescence typically occurs by day 3-5 of effective therapy; cephalosporins can produce slower defervescence than fluoroquinolones.
  • Most uncomplicated cases can be treated as outpatients with oral antibiotics; hospitalize patients with persistent vomiting, diarrhea, abdominal distension, or signs of complications, and give parenteral therapy.

2. Adjunctive Steroids (Severe Disease)

For severe enteric fever complicated by shock, delirium, or obtundation, dexamethasone reduces mortality: initial dose 3 mg/kg IV, followed by 1 mg/kg every 6 hours for 48 hours (total 8 additional doses). Do not continue beyond 48 hours - prolonged use can increase relapse risk and can mask signs of intestinal perforation. Avoid salicylates.

3. Supportive Care

  • IV fluids/saline, correction of electrolyte and acid-base disturbances
  • Blood transfusion if significant intestinal hemorrhage
  • Abdominal imaging if perforation is suspected (free air); urgent laparotomy if perforation is confirmed, with broadening of antibiotic coverage to include bowel flora (anaerobes/gram-negatives)

4. Chronic Carriers (~2-5% of patients)

  • Fluoroquinolone-susceptible strains: 4 weeks of oral ciprofloxacin (~80% eradication)
  • Fluoroquinolone-resistant strains: 4-week course of oral azithromycin (limited data) or amoxicillin (lower eradication rates)
  • If anatomic abnormality present (gallstones, renal/bladder stones), eradication often needs antibiotics plus surgical correction (e.g., cholecystectomy)

5. Prevention

Typhoid conjugate vaccines (e.g., Typbar TCV) are now WHO-recommended for endemic, high-burden settings and provide durable protection even in young children; older Ty21a (oral live attenuated) and Vi polysaccharide vaccines remain options for travelers, with efficacy of roughly 50-80%.
Sources: Harrison's Principles of Internal Medicine, 22E, p. 1358-1360; Goldman-Cecil Medicine, International Edition, p. 1963-1973.

Recent evidence check

A 2024 systematic review of RCTs (PMID 39623850) found oral azithromycin has comparable efficacy to ceftriaxone, fluoroquinolones, and chloramphenicol for typhoid across age groups, supporting its role as an oral option in resistant settings. A 2022 Cochrane review (PMC9686137) similarly found no clear difference between ceftriaxone and azithromycin/fluoroquinolones/chloramphenicol, though cefixime may be somewhat less effective than fluoroquinolones. These are consistent with the textbook guidance above, no major contradictions. A newer 2025 Cochrane review (PMID 40326553) focuses on typhoid conjugate vaccines for prevention rather than treatment.
If you want, I can tailor this to a specific patient scenario - pregnancy, pediatric dosing, travel-related exposure to a specific region, or a suspected complication like perforation.
This is a shared conversation. Sign in to Orris to start your own chat.